Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp171 | Cell biology: osteoblasts and bone formation | ECTS2013

In vitro effect of prolactin on the osteogenic potential of bone marrow mesenchymal stem cells of rats

de Melo Ocarino Natalia , Silvia Silva Santos , Rocha Lorena , Freitas Juneo , Sena Reis Amanda Maria , Serakides Rogeria

The effects of prolactin on bone metabolism have been the subjects of several studies. It is believed that prolactin acts directly influencing the synthesis of bone matrix by stimulating the osteoblastic activity, since receptors for this hormone have been identified in osteoblasts and human mesenchymal stem cells (MSCs). However, no study on the effects of prolactin on the osteogenic differentiation of MSCs was found in the literature. The objective of this study was to verif...

ba0001pp189 | Cell biology: osteoblasts and bone formation | ECTS2013

Integrins and cadherins in mesenchymal stem cells from dental tissues: possible implication in the osteogenic differentiation process

Di Benedetto Adriana , Carbone Claudia , Oranger Angela , Brunetti Giacomina , Lorenzo Lo Muzio , Colucci Silvia , Grano Maria , Mori Giorgio

Numerous studies have reported beneficial effects of multipotent mesenchymal stem cells (MSCs) in tissue repair and regeneration. These multipotent cells can be isolated from many different adult tissues and give rise to different cell lineages. The most well-characterized source for adult stem cells is still adult bone marrow, however in the past decade, subpopulations of stem cells have been isolated from dental tissues. Dental pulp has been identified as a promising source ...

ba0001pp378 | Osteoporosis: pathophysiology and epidemiology | ECTS2013

Role of Wnt antagonists (sclerostin and Dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury: preliminary results

Gifre Laia , Vidal Joan , Ruiz-Gaspa Silvia , Portell Enric , Monegal Ana , Muxi Africa , Guanabens Nuria , Peris Pilar

Spinal cord injury (SCI) has been associated with a marked increase in bone loss. This study analysed the effect of Wnt signalling antagonists (sclerostin and DKK-1) and their relationship with bone turnover markers and BMD evolution in patients with a recent SCI.Methods: Patients with a recent complete motor SCI (AIS A or B); (<6 months) were prospectively included. Bone turnover markers (bone formation: P1NP, bone AP; bone resorption: sCTx), Wnt an...

ba0002oc30 | Chronic diseases | ICCBH2013

Alteration of wnt/β-catenin signaling in HIV-infected youths: a mechanism leading to impaired bone health?

Mora Stefano , Giacomet Vania , Puzzovio Maria , Maruca Katia , Stucchi Sara , Erba Paola , Capelli Silvia , Vigano Alessandra , Zuccotti Gian Vincenzo

Objectives: Impairment of bone mass accrual and alterations of bone metabolism is a common finding in HIV-infected youths. In particular, previous studies demonstrated higher bone formation and bone resorption rates in HIV-infected children and adolescents. Wnt ligands promote bone formation by stimulating osteoblast differentiation and their survival. Recent studies demonstrated that sclerostin (Scl) and dickkopf factor 1 (DKK-1), Wnt antagonists, are important negative regul...

ba0003pp26 | Bone biomechanics and quality | ECTS2014

Structural analysis of tooth and jawbone in a type 2 diabetes mouse model

Pabisch Silvia , Yamaguchi Tsuguno , Koike Yasushi , Egashira Kenji , Kataoka Shinsuke , Wagermaier Wolfgang , Weinkamer Richard , Murakoshi Michiaki , Fratzl Peter

In type 2 diabetes mellitus (T2DM) patients, an increased fracture risk is observed, although the bone mineral density is even higher than in non-diabetic patients, which raises the question of the quality of the organic and inorganic matrix in bone1,2. T2DM is also known to favor inflammation of the gingiva and paradontosis in general. However, little is known about the mineral nano-architecture in the mandible and about the possible influence of diabetes. Using sy...

ba0003pp139 | Cell biology: osteoblasts and bone formation | ECTS2014

Effect of lactation on the osteogenic potential of bone marrow mesenchymal stem cells of rats

Sena Reis Amanda Maria , de Freitas Silva Juneo , Santos Silvia Silva , Serakides Rogeria , de Melo Ocarino Natalia

The lactation has been considered a cause of bone loss in humans and animals. Studies have shown that during lactation, there is a significant reduction of bone mineral density. Rats at the end of lactation show reduced bone mass. The objective of this study was to verify the effect of lactation under osteogenic potential of bone marrow mesenchymal stem cells (BMMSCs) of female rats. Twelve Wistar rats were distributed among the control and lactating groups. The experiment was...

ba0003pp212 | Muscle, physical activity and bone | ECTS2014

New insights in the bone-muscle axis: the novel myokine irisin is involved in skeletal metabolism

Colaianni Graziana , Cuscito Concetta , Mongelli Teresa , Oranger Angela , Mori Giorgio , Brunetti Giacomina , Colucci Silvia , Cinti Saverio , Grano Maria

It has been recently reported that, after physical exercise activity, the skeletal muscle releases Irisin, the newly identified myokine able of driving transition of white adipocytes to brown, following a phenomenon known as the browning response. This result has suggested that skeletal muscle is crucial in the regulation of energy homeostasis, supporting the idea that it can be considered an endocrine organ that targets adipose tissue by promoting energy expenditure. In accor...

ba0003pp259 | Osteoporosis: pathophysiology and epidemiology | ECTS2014

High sclerostin levels in primary biliray cirrhosis: relationship with cholestasis and bone remodelling

Ruiz-Gaspa Silvia , Gifre Laia , Pares Albert , Miquel Rosa , Peris Pilar , Monegal Ana , Dubreuil Marta , Arias Ana , Guanabens Nuria

Background and aims: Low bone formation is the main pathogenic mechanism of osteoporosis in primary biliary cirrhosis (PBC). Sclerostin, an inhibitor of the Wnt pathway, is involved in the regulation of osteoblastogenesis and little is known about its role in the development of bone disease in PBC. Thus, we evaluated the circulating levels of sclerostin and its relationship to bone mass, the parameters of mineral metabolism and liver disease severity.Met...

ba0003pp321 | Osteoporosis: treatment | ECTS2014

On-treatment safety and efficacy and short-term efficacy of 1--34 parathyroid hormone treatment in severe osteoporosis

Torrente-Segarra Vicenc , Roig Daniel , Cerda Dacia , Reina Delia , Garcia-Diaz Silvia , Estrada Paula , Figuls Ramon , Corominas Hector

Objectives: To assess safety and clinical efficacy during 1–34 parathyroid hormone treatment (1–34-PTH) in real clinical practice; to describe fracture outcome after 1–34-PTH discontinuation in real clinical practice.Methods: We performed an observational study in real clinical practice of all consecutive severe osteoporosis (sOP) patients referred to our Rheumatology Department from Feb’10 until Jan’14. All patients were referre...